PHAT Competitors & Alternatives
Compare Phathom Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
PHAT
Main Stock$6.26
Tradestie Score
65
Market Cap
$871.90M
Revenue Growth
0.7%
Analyst Upside
+220.3%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$9.73
|
$468.01M | - | 43 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$9.43
|
$463.20M | - | 37 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$7.18
|
$457.09M | - | 35 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$7.69
|
$454.29M | - | 44 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 50 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$13.05
|
$448.32M | - | 42 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 54 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$6.32
|
$422.50M | - | 40 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$12.32
|
$407.71M | - | 56 | Compare |
More PHAT Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry